Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
Director departure
|
|
Paratek Pharmaceuticals, Inc. (PRTK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/20/2023 |
SC 13G/A
| HIRSCHMAN ORIN reports a 4.9% stake in Paratek Pharmaceuticals, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/20/2023 |
SC 13G/A
| NexPoint Real Estate Opportunities, LLC reports a 7% stake in Paratek Pharmaceuticals, Inc. |
| 07/07/2022 |
SC 13G/A
| HIRSCHMAN ORIN reports a 7.7% stake in Paratek Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 4.3% stake in Paratek Pharmaceuticals, Inc. |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 7.6% stake in Paratek Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 3.8% stake in Paratek Pharmaceuticals, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7% stake in PARATEK PHARMACEUTICALS INC |
| 12/09/2019 |
SC 13G/A
| Baupost Group reports a 4.7% stake in Paratek Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Baupost Group reports a 8.6% stake in Paratek Pharmaceuticals, Inc. |
| 02/13/2018 |
SC 13G/A
| FMR LLC reports a 4.8% stake in PARATEK PHARMACEUTICALS INC |
| 01/29/2018 |
SC 13G/A
| BlackRock Inc. reports a 6.8% stake in PARATEK PHARMACEUTICALS INC |
| 03/22/2017 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 5% stake in PARATEK PHARMACEUTICALS, INC. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/27/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/04/2011 |
SC 13G/A
| Transcept Pharmaceuticals Inc has filed a Schedule 13D for Transcept Pharmaceuticals, INC. |
| 01/03/2011 |
SC 13G/A
| Transcept Pharmaceuticals Inc reports a 9% stake in Transcept Pharmaceuticals, Inc. |
| 02/16/2010 |
SC 13G/A
| Transcept Pharmaceuticals Inc reports a 9% stake in Transcept Pharmaceuticals, Inc. |
| 02/12/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/19/2010 |
SC 13G/A
| DOMAIN PARTNERS V LP reports a 0% stake in Transcept Pharmaceuticals, Inc. |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/13/2009 |
SC 13G/A
| SOFINNOVA VENTURE PARTNERS V LP reports a 8.9% stake in Novacea, Inc. |
| 01/16/2009 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 5.8% stake in NOVACEA, INC. |
|
|